K L Haywood1, A M Garratt, P T Dawes. 1. Unit of Health-Care Epidemiology, Department of Public Health, University of Oxford, Oxford OX3 7LF, UK. kirstie.haywood@uhce.ox.ac.uk
Abstract
OBJECTIVE: To review evidence relating to the measurement properties for all disease-specific, multi-item, patient-assessed health instruments in patients with ankylosing spondylitis (AS). METHODS: Systematic literature searches were made to identify instruments, using predefined criteria relating to reliability, validity, responsiveness and precision. RESULTS: Twelve AS-specific and three arthritis-specific instruments met the inclusion criteria. Three AS-specific instruments that measure health-related quality of life (HRQL) were reviewed. The Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), the Bath Ankylosing Spondylitis Functional Index (BASFI) and the Dougados Functional Index (DFI) had the greatest amount of evidence for reliability, validity and responsiveness across a range of settings. Four instruments lacked evidence for test-retest or internal consistency reliability. Most were assessed for validity through comparisons with other instruments, global judgements of health, mobility or clinical and sociodemographic variables. Most were assessed for responsiveness through mean score changes. Three instruments lacked evidence of responsiveness. CONCLUSION: This review provides a contribution to AS assessment. AS-specific multi-item measures specific to the assessment of pain, stiffness, fatigue and global health were not identified; where assessed, these domains were largely measured with single-item visual analogue scales. Single items may provide a limited reflection of these important domains. The BASFI and DFI remain the instruments of choice for functional assessment. HRQL is recommended as a core assessment domain. Further concurrent evaluation is recommended.
OBJECTIVE: To review evidence relating to the measurement properties for all disease-specific, multi-item, patient-assessed health instruments in patients with ankylosing spondylitis (AS). METHODS: Systematic literature searches were made to identify instruments, using predefined criteria relating to reliability, validity, responsiveness and precision. RESULTS: Twelve AS-specific and three arthritis-specific instruments met the inclusion criteria. Three AS-specific instruments that measure health-related quality of life (HRQL) were reviewed. The Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), the Bath Ankylosing Spondylitis Functional Index (BASFI) and the Dougados Functional Index (DFI) had the greatest amount of evidence for reliability, validity and responsiveness across a range of settings. Four instruments lacked evidence for test-retest or internal consistency reliability. Most were assessed for validity through comparisons with other instruments, global judgements of health, mobility or clinical and sociodemographic variables. Most were assessed for responsiveness through mean score changes. Three instruments lacked evidence of responsiveness. CONCLUSION: This review provides a contribution to AS assessment. AS-specific multi-item measures specific to the assessment of pain, stiffness, fatigue and global health were not identified; where assessed, these domains were largely measured with single-item visual analogue scales. Single items may provide a limited reflection of these important domains. The BASFI and DFI remain the instruments of choice for functional assessment. HRQL is recommended as a core assessment domain. Further concurrent evaluation is recommended.
Authors: Lidwine B Mokkink; Caroline B Terwee; Paul W Stratford; Jordi Alonso; Donald L Patrick; Ingrid Riphagen; Dirk L Knol; Lex M Bouter; Henrica C W de Vet Journal: Qual Life Res Date: 2009-02-24 Impact factor: 4.147
Authors: Yuen Ling Elaine Au; Woon Sing Raymond Wong; Mo Yin Mok; Ho Yin Chung; Eric Chan; Chak Sing Lau Journal: Clin Rheumatol Date: 2014-07-01 Impact factor: 2.980
Authors: Agustí Sellas I Fernandez; Xavier Juanola Roura; Alberto Alonso Ruiz; José Rosas; Julio Medina Luezas; Eduardo Collantes Estevez; Miguel Ángel Abad Hernández; Virginia Carrasco Benitez; Cesar Fisac Journal: Rheumatol Int Date: 2017-09-16 Impact factor: 2.631
Authors: Tamar F Brionez; Shervin Assassi; John D Reveille; Charles Green; Thomas Learch; Laura Diekman; Michael M Ward; John C Davis; Michael H Weisman; Perry Nicassio Journal: J Rheumatol Date: 2010-02-15 Impact factor: 4.666
Authors: J Karami; M Mahmoudi; A Amirzargar; M Gharshasbi; A Jamshidi; S Aslani; M H Nicknam Journal: Genes Immun Date: 2017-08-10 Impact factor: 2.676
Authors: Siddharth Bethi; Abhijit Dasgupta; Michael H Weisman; Thomas J Learch; Lianne S Gensler; John C Davis; John D Reveille; Michael M Ward Journal: Arthritis Care Res (Hoboken) Date: 2013-04 Impact factor: 4.794